NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025
- Framework
- Membership closed
- Established 2025
Operated by NHS England
21
Appointed members
24
Call-offs recorded
Members see what actually flows through this framework, the fit score for their business, and an estimated reopening window.